Learning Objectives and Intended Audiences

Intended Audience

The intended audience for this event includes dermatologists, dermatology residents/fellows, dermatology nurse practitioners and physician assistants specializing in diagnosis, management and treatment of patient outcomes in medical, surgical and aesthetic dermatology.

Upon completion of this live activity participants should be able to:

  1. Summarize current and emerging therapies that hold promise for the effective treatment of skin cancers including actinic keratosis, basal cell carcinoma and melanoma.
  2. Define intrinsic and extrinsic factors of the normal aging process in patients with all skin types
  3. Select and formulate the appropriate aesthetic treatment plan using neurotoxins, dermal fillers, laser and light-based energy therapy technologies and cosmeceutical products in patients of all skin types who seek improvement in facial and skin appearance
  4. Compare patient selection, choice of injectable products and technique required to avoid potential complications and achieve optimal patient outcomes.
  5. Express current understanding of the pathophysiology of acne as it relates to effective diagnosis and treatment
  6. Discuss current theories on the pathogenesis of rosacea including the identification of genetic factors and gene loci that predispose affected patients to a rosacea phenotype
  7. Analyze evidence-based data on acne treatment options in order to improve treatment outcomes and improve patient adherence to therapy.
  8. Examine emerging clinical and therapeutic science insights into the pathogenesis and effective management of atopic dermatitis.
  9. Summarize the recently published AAD clinical guidelines on the management of atopic dermatitis
  10. Discuss the role of the innate and adaptive immune system function in normal skin and how changes in the immune system may contribute to inflammatory disease
  11. Assess evidence-based data on the relationship between psoriasis comorbidities and therapeutic selection
  12. Identify the psoriasis patient population that would benefit most from treatment with biologic response modifiers
  13. Indicate the types of superficial fungal infection presenting in the dermatology setting
  14. Formulate optimal treatment plans for difficult to treat onychomycosis and cutaneous superficial fungal infections including tinea pedis, tinea cruris and tinea corpori